[Postpartum pseudomembranous colitis].
D000328:Adult; D002439:Cefotaxime / Q000009:adverse effects*; D003106:Colon / Q000473:pathology; D003113:Colonoscopy; D004359:Drug Therapy, Combination; D004761:Enterocolitis, Pseudomembranous / Q000139:chemically induced* / Q000473:pathology; D005260:Female; D005839:Gentamicins / Q000009:adverse effects*; D006801:Humans; D007044:Hysterectomy; D008768:Methylmethacrylates / Q000009:adverse effects*; D008795:Metronidazole / Q000009:adverse effects*; D007744:Obstetric Labor Complications / Q000175:diagnosis; D011247:Pregnancy; D011644:Puerperal Disorders / Q000139:chemically induced* / Q000473:pathology; D012769:Shock / Q000150:complications; D014592:Uterine Hemorrhage / Q000150:complications; D014640:Vancomycin / Q000627:therapeutic use
D005839:Gentamicins; D008768:Methylmethacrylates; C030159:gentamicin-polymethylmethacrylate bead; D008795:Metronidazole; D014640:Vancomycin; D002439:Cefotaxime
Postpartale pseudomembranöse Kolitis.